OTCMKTS:GNGBY

Getinge AB (publ) - GNGBY Price Target & Analyst Ratings

$24.32

+0.21 (+0.87%)

(As of 03/31/2023 12:00 AM ET)

Add

Compare

Today's Range: $24.32
▼
$24.35
50-Day Range: $20.26
▼
$24.84
52-Week Range: $15.87
▼
$41.54

Volume: 14,492 shs
Average Volume: 7,893 shs
Market Capitalization: $6.62 billion

P/E Ratio: 27.02
Dividend Yield: 1.23%
Price Target: N/A

Getinge AB (publ) Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 7 Analyst Ratings

Consensus Analyst Price Target

N/A

Type	Current 4/1/22 to 4/1/23	1 Month Ago 3/2/22 to 3/2/23	3 Months Ago 1/1/22 to 1/1/23	1 Year Ago 4/1/21 to 4/1/22
Consensus Rating	Hold	Hold	Hold	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)
Hold	4 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	2 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	$41.32
Predicted Upside	N/A	N/A	N/A	N/A

Get Getinge AB (publ) Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GNGBY and its competitors with MarketBeat's FREE daily newsletter.

GNGBY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GNGBY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Getinge AB (publ) Stock vs. The Competition

Type	Getinge AB (publ)	Medical Companies	S&P 500
Consensus Rating Score	2.14	2.64	2.48
Consensus Rating	Hold	Buy	Hold
Predicted Upside		1,994.81% Upside	97.23% Upside
News Sentiment Rating	Neutral News	Neutral News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target
2/2/2023	Pareto Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
1/18/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	SEK 274 ➝ SEK 250
1/3/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underweight
12/30/2022	DNB Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
10/20/2022	Nordea Equity Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
6/13/2022	Cheuvreux Subscribe to MarketBeat All Access for the recommendation accuracy rating	Oliver Reinberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	SEK 435 ➝ SEK 280

6/13/2022	Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Oliver Reinberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	SEK 435 ➝ SEK 280
3/9/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold
10/28/2021	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
7/26/2021	AlphaValue Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Reduce ➝ Buy	$41.32
3/11/2021	SEB Equity Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
3/11/2021	SEB Equities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
9/9/2020	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy

(Data available from 4/1/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

GNGBY Price Target - Frequently Asked Questions

What is Getinge AB (publ)'s consensus rating?: According to the issued ratings of 7 analysts in the last year, the consensus rating for Getinge AB (publ) stock is Hold based on the current 1 sell rating, 4 hold ratings and 2 buy ratings for GNGBYthe . Learn more on GNGBY's analyst rating history.
Do Wall Street analysts like Getinge AB (publ) more than its competitors?: Analysts like Getinge AB (publ) less than other Medical companies. The consensus rating for Getinge AB (publ) is Hold while the average consensus rating for medical companies is Buy. Learn more on how GNGBY compares to other companies.
Is Getinge AB (publ) being downgraded by Wall Street analysts?: Over the previous 90 days, Getinge AB (publ)'s stock had 2 downgrades by analysts.

What analysts cover Getinge AB (publ)?: Getinge AB (publ) has been rated by JPMorgan Chase & Co., Morgan Stanley, and Pareto Securities in the past 90 days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

This page (OTCMKTS:GNGBY) was last updated on 4/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial